[Federal Register: January 21, 2003 (Volume 68, Number 13)]


[Page 2784]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]




Food and Drug Administration


Vaccines and Related Biological Products Advisory Committee; 

Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.


    This notice announces a forthcoming meeting of a public advisory 

committee of the Food and Drug Administration (FDA). At least one 

portion of the meeting will be closed to the public.

    Name of Committee: Vaccines and Related Biological Products 

Advisory Committee.

    General Function of the Committee: To provide advice and 

recommendations to the agency on FDA's regulatory issues.

    Date and Time: The meeting will be held on February 20, 2003, from 

8:30 a.m. to 4:30 p.m.

    Location: Holiday Inn, 8120 Wisconsin Ave., Bethesda, MD.

    Contact Person: Jody G. Sachs or Denise H. Royster, Center for 

Biologics Evaluation and Research (HFM-71), Food and Drug 

Administration, 1401 Rockville Pike, Rockville, MD 20852, 301-827-0314, 

or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-

0572 in the Washington, DC area), code 12391. Please call the 

Information Line for up-to-date information on this meeting.

    Agenda: The committee will review and discuss the selection of 

strains to be included in the influenza virus vaccine for the 2003-2004 

season and the intramural research program of the Laboratory of 

Bacterial Polysaccharides, Office of Vaccines Research and Review.

    Procedure: On February 20, 2003, from 8:30 a.m. to 3:20 p.m., the 

meeting is open to the public. Interested persons may present data, 

information, or views, orally or in writing, on issues pending before 

the committee. Written submissions may be made to the contact person by 

February 4, 2003. Oral presentations from the public will be scheduled 

between approximately 1 p.m. and 1:30 p.m. and 2:50 p.m. and 3:20 p.m. 

Time allotted for each presentation may be limited. Those desiring to 

make formal oral presentations should notify the contact person before 

February 4, 2003, and submit a brief statement of the general nature of 

the evidence or arguments they wish to present, the names and addresses 

of proposed participants, and an indication of the approximate time 

requested to make their presentation.

    Closed Committee Deliberations: On February 20, 2003, from 3:20 

p.m. to 4:30 p.m., the meeting will be closed to permit discussion 

where disclosure would constitute a clearly unwarranted invasion of 

personal privacy (5 U.S.C. 552b(c)(6)).

    Persons attending FDA's advisory committee meetings are advised 

that the agency is not responsible for providing access to electrical 


    FDA welcomes the attendance of the public at its advisory committee 

meetings and will make every effort to accommodate persons with 

physical disabilities or special needs. If you require special 

accommodations due to a disability, please contact Jody G. Sachs or 

Denise H. Royster at least 7 days in advance of the meeting.

    Notice of this meeting is given under the Federal Advisory 

Committee Act (5 U.S.C. app. 2).

    Dated: January 10, 2003.

Linda Arey Skladany,

Associate Commissioner for External Relations.

[FR Doc. 03-1208 Filed 1-17-03; 8:45 am]